Gurbakhash N M N Kaur

24PUBLICATIONS
190CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityMedical mycologyRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 02, 2026
Real-world outcomes with BCMA- and GPRC5D-targeting bispecific antibodies in plasma cell leukemia.

|Nov 28, 2025
The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience.

Aimaz Afrough, Danai Dima, Beatrice Razzo

|Nov 26, 2025
Polymorphic IGLV6-57 AL amyloid fibrils and features of a shared folding pathway.

Parker T Bassett, Binh A Nguyen, Virender Singh

|Aug 19, 2025
Prospective real-world evaluation of t(11;14) prevalence and disease biology in multiple myeloma: MEDICI study analysis.

Andrew Spencer, Maria Gavriatopoulou, Daniel Coriu

|Aug 13, 2025
Clonal Hematopoiesis and Inflammation Predict Hematologic Toxicity and Secondary Myeloid Malignancies after B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-cell Therapy.

Zachary M Avigan, Jerrel Catlett, Saoirse Bodnar

|Jul 21, 2025
Immunoglobulin prophylaxis should be initiated after bispecific antibody therapy in multiple myeloma, regardless of IgG levels.

Rahul Banerjee, Meera Mohan, Kai Rejeski

Pageof 4

Frequent Collaborators

14 joint publications

Larry D Anderson

12 joint publications

Rahul Banerjee

10 joint publications

Krina Patel

10 joint publications

James A Davis